Like little kids on a road trip, those of us in healthcare keep asking about biosimilars, “are we there yet?” And like most parents, we keep saying, “soon.” Regular updates are important, however, to keep us engaged and motivated to make optimal use of these beneficial agents as they become available. Read More ›
Biosimilars have been available in the United States for more than 5 years, and in Europe for more than 15 years, yet we still see reluctance in the adoption of these drugs. Read More ›
